Particle Data Platform

Mice With ALS Don’t Die

27:1428:00 · 46s

Lane claims their device treatment keeps ALS transgenic mice alive and running if administered biweekly, projecting human dosing every 3–4 months.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.